Clinical trials recruiting for Hepatocarcinoma
4
Recruiting trials
0
US states with sites
3
Countries
25%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 3 1Not applicable 3
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy | 1 |
| Hepatocellular carcinoma | 1 |
| Pancreatic adenocarcinoma | 1 |
| Pancreatic neuroendocrine tumor | 1 |
Self-screener
Recruiting trials
- A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
- Evaluation of Skin Tests in Biotherapy Allergies
- METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors
- Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Related conditions
Trials recruiting for Hepatocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870Melanoma 487Colorectal cancer 1359Ovarian cancer 118Lung cancer 2180Cervical cancer 71Breast cancer 2239Vulva Cancer 4Renal Cancer 18Pleural Mesothelioma 9
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Hepatocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.